Clinical Trial Update: NovaTears® Eye Drops Observational Study NT-002

View source ↗

Summary

The document notes the completion of the NT-002 observational study of NovaTears Eye Drops, sponsored by Novaliq GmbH, in patients with dry eye syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• NovaTears Eye Drops (perfluorohexyloctane)

Snippet

Sponsor: Novaliq GmbH | Conditions: Dry Eye Syndromes | Status: COMPLETED